Andrew Hayhurst, Texas Biomedical Research Institute (IMAGE)
Caption
Dr. Andrew Hayhurst, scientist at Texas Biomed has received an NIH RO1 grant to continue research on llama antibodies as a potential diagnostic for filoviruses, such as Ebola and Marburg.
Credit
Courtesy of Texas Biomed
Usage Restrictions
None
License
Licensed content